Cargando…
Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
BACKGROUND: It has been generally accepted that people with MS (PwMS) should be vaccinated against COVID-19. The aim of our investigation was to evaluate the humoral response to natural SARS-CoV-2 infection and to two COVID-19 vaccines (BNT162b2 Pfizer-BioNTech and Beijing/Sinopharm BBIBP-CorV) in o...
Autores principales: | Drulovic, Jelena, Ivanovic, Jovana, Martinovic, Vanja, Tamas, Olivera, Veselinovic, Nikola, Cujic, Danica, Gnjatovic, Marija, Mesaros, Sarlota, Pekmezovic, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280377/ https://www.ncbi.nlm.nih.gov/pubmed/34298478 http://dx.doi.org/10.1016/j.msard.2021.103150 |
Ejemplares similares
-
Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment
por: Jovicevic, Vanja, et al.
Publicado: (2022) -
COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
por: Jovicevic, Vanja, et al.
Publicado: (2022) -
In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
por: Cavalli, Eugenio, et al.
Publicado: (2019) -
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial
por: Nedeljkovic, Una, et al.
Publicado: (2015) -
Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis
por: Drulović, Jelena, et al.
Publicado: (2017)